Articles related to Cardiology, Interventional

Stay informed about recent recalls to ensure patient safety. Learn more about the recall of a blood pressure medication contaminated with oxycodone.

Discover how MPO testing can offer a more comprehensive understanding of your patients’ health risks, including mortality beyond cardiovascular disease.

A recent Swedish study reveals a significant, graded association between elevated blood pressure in late adolescence and future cardiovascular risks. Early intervention may be key to mitigating long-term health outcomes.

Marlex Pharmaceuticals has initiated a critical recall of specific lots of Digoxin Tablets due to a labeling error. Physicians are urged to exercise extreme caution and verify their inventory to prevent adverse patient outcomes.

Gain insights into the ethical and medical complexities of determining death with the ACP’s latest position paper. Equip yourself with the knowledge and guidelines to navigate this critical aspect of patient care.

Curious about the best approach for cardiovascular risk assessment in asymptomatic adults? Dive into this quiz to explore evidence-based recommendations.